[Use of rovamycin and amox-clav in patients with infectious-inflammatory pathology of the ORL organs].
Clinical and microbiological findings led the authors to the conclusion that antibacterial drugs rovamycin and amox-clav are active against ENT infection and inflammation. The trial included 69 and 42 patients given rovamycin and amox-clav, respectively.